Simplex Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-14,725
| Closed | -$120K | – | 11963 |
|
|
2021
Q3 | $120K | Sell |
14,725
-1,200
| -8% | -$7.48K | ﹤0.01% | 6363 |
|
|
2021
Q2 | $131K | Sell |
15,925
-4,215
| -21% | -$35.8K | ﹤0.01% | 6352 |
|
|
2021
Q1 | $180K | Buy |
20,140
+5,976
| +42% | +$68.5K | ﹤0.01% | 4907 |
|
|
2020
Q4 | $163K | Buy |
14,164
+8,499
| +150% | +$98.8K | ﹤0.01% | 4878 |
|
|
2020
Q3 | $58K | Buy |
+5,665
| New | +$69.4K | ﹤0.01% | 5478 |
|
|
2020
Q2 | – | Sell |
-6,426
| Closed | -$66.6K | – | 8696 |
|
|
2020
Q1 | $50K | Sell |
6,426
-47,319
| -88% | -$713K | ﹤0.01% | 5134 |
|
|
2019
Q4 | $1.11M | Buy |
53,745
+48,176
| +865% | +$812K | ﹤0.01% | 1997 |
|
|
2019
Q3 | $76K | Sell |
5,569
-4,668
| -46% | -$55.4K | ﹤0.01% | 4624 |
|
|
2019
Q2 | $125K | Sell |
10,237
-13,352
| -57% | -$154K | ﹤0.01% | 3962 |
|
|
2019
Q1 | $294K | Buy |
+23,589
| New | +$315K | ﹤0.01% | 3213 |
|
|
2016
Q4 | – | Sell |
-9,297
| Closed | -$178K | – | 6795 |
|
|
2016
Q3 | $181K | Buy |
9,297
+8,889
| +2,179% | +$150K | 0.01% | 1102 |
|
|
2016
Q2 | $6K | Buy |
+408
| New | +$5.13K | ﹤0.01% | 4151 |
|
|
2016
Q1 | – | Sell |
-3,909
| Closed | -$47.4K | – | 6518 |
|
|
2015
Q4 | $75K | Buy |
3,909
+2,564
| +191% | +$44.5K | 0.01% | 1588 |
|
|
2015
Q3 | $19K | Buy |
+1,345
| New | +$31.6K | ﹤0.01% | 2862 |
|
Simplex Trading's FLXN Position: Q4 2021 in Review
Simplex Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 14,725 shares — an estimated $120K sold.
Simplex Trading first reported a position in FLXN in Q3 2015 and held it in 14 quarters. The position peaked at $1.11M in Q4 2019. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Simplex Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Simplex Trading sold 14,725 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $120K.
- Simplex Trading first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 14 quarters.
- Simplex Trading's Flexion Therapeutics, Inc. position peaked at $1.11M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.